Free Trial
NYSE:AFL

Aflac Q2 2025 Earnings Report

Aflac logo
$104.57 +1.05 (+1.01%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$103.50 -1.07 (-1.02%)
As of 07/3/2025 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aflac EPS Results

Actual EPS
N/A
Consensus EPS
$1.73
Beat/Miss
N/A
One Year Ago EPS
N/A

Aflac Revenue Results

Actual Revenue
N/A
Expected Revenue
$4.30 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aflac Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aflac? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aflac and other key companies, straight to your email.

About Aflac

Aflac (NYSE:AFL) (NYSE: AFL) is a leading provider of supplemental insurance products designed to help policyholders manage out-of-pocket expenses not covered by primary health and life insurance plans. Established in 1955 and headquartered in Columbus, Georgia, the company has built a reputation for delivering innovative cash-benefit policies that pay insured individuals directly, regardless of other coverage. Aflac’s product portfolio includes accident, cancer, critical illness, short-term disability, dental and vision, as well as life insurance, all aimed at filling gaps in traditional health care coverage and providing financial security when unexpected medical events occur.

While Aflac maintains a strong presence in the United States, its operations in Japan account for a significant portion of its premium income. The company entered the Japanese market in 1974 and introduced the first cancer insurance policy there in 1976. Since then, Aflac Japan has become one of the nation’s top insurers, credited with pioneering supplemental health insurance in that market. In the U.S., Aflac has forged strategic partnerships with employers, brokers and financial institutions to distribute its products through workplace benefits programs and affinity arrangements.

Over its more than six decades of operation, Aflac has emphasized customer service, fast claim processing and transparent policy terms. Technological enhancements, such as mobile apps and online portals, enable policyholders in both regions to manage their accounts and submit claims efficiently. The company is also committed to community engagement and philanthropic efforts through the Aflac Cancer Center and Blood Disorders Service at Children’s Healthcare of Atlanta, reflecting its longstanding dedication to cancer research and patient support.

Leadership at Aflac is anchored by Daniel P. Amos, who has served as chairman and chief executive officer since 2000 and represents the third generation of Amos family leadership. Under his guidance, the company has expanded its international footprint and diversified its product lineup. Aflac’s executive team includes seasoned professionals in underwriting, risk management, finance and digital innovation, all working to sustain growth and maintain Aflac’s reputation as a reliable partner in supplemental insurance solutions.

View Aflac Profile

More Earnings Resources from MarketBeat